Mangia A - Search Results

1

Clinical significance of the CCR5delta32 allele in hepatitis C.

Morard I, Clément S, Calmy A, Mangia A, Cerny A, De Gottardi A, Gorgievski M, Heim M, Malinverni R, Moradpour D, Müllhaupt B, Semela D, Pascarella S, Bochud PY, Negro F; Swiss Hepatitis C Cohort Study Group. Morard I, et al. Among authors: mangia a. PLoS One. 2014 Sep 5;9(9):e106424. doi: 10.1371/journal.pone.0106424. eCollection 2014. PLoS One. 2014. PMID: 25191700 Free PMC article.

2

Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients.

Mangia A, Andriulli A, Zenarola P, Lomuto M, Cascavilla I, Quadri R, Negro F. Mangia A, et al. J Med Virol. 1999 Nov;59(3):277-80. doi: 10.1002/(sici)1096-9071(199911)59:3<277::aid-jmv3>3.0.co;2-e. J Med Virol. 1999. PMID: 10502256

3

A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C.

Mangia A, Minerva N, Annese M, Leandro G, Villani MR, Santoro R, Carretta V, Bacca D, Giangaspero A, Bisceglia M, Ventrella F, Dell'Erba G, Andriulli A. Mangia A, et al. Hepatology. 2001 Apr;33(4):989-93. doi: 10.1053/jhep.2001.23537. Hepatology. 2001. PMID: 11283865 Clinical Trial.

4

High doses of interferon in combination with ribavirin are more effective than the standard regimen in patients with HCV genotype 1 chronic hepatitis.

Mangia A, Santoro R, Piattelli M, Leandro G, Minerva N, Annese M, Bacca D, Spirito F, Carretta V, Ventrella F, Cela M, Andriulli A. Mangia A, et al. J Hepatol. 2002 Jul;37(1):109-16. doi: 10.1016/s0168-8278(02)00140-x. J Hepatol. 2002. PMID: 12076869 Clinical Trial.

5

Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials.

Mangia A, Leandro G, Helbling B, Renner EL, Tabone M, Sidoli L, Caronia S, Foster GR, Zeuzem S, Berg T, Di Marco V, Cino N, Andriulli A. Mangia A, et al. J Hepatol. 2004 Mar;40(3):478-83. doi: 10.1016/j.jhep.2003.11.002. J Hepatol. 2004. PMID: 15123363

6

Treatment of patients with HCV infection with or without liver biopsy.

Andriulli A, Persico M, Iacobellis A, Maio G, Di Salvo D, Spadaccini A, Bacca D, Leandro G, Ventrella F, Mangia A. Andriulli A, et al. Among authors: mangia a. J Viral Hepat. 2004 Nov;11(6):536-42. doi: 10.1111/j.1365-2893.2004.00519.x. J Viral Hepat. 2004. PMID: 15500554 Clinical Trial.

7

An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.

Abid K, Pazienza V, de Gottardi A, Rubbia-Brandt L, Conne B, Pugnale P, Rossi C, Mangia A, Negro F. Abid K, et al. Among authors: mangia a. J Hepatol. 2005 May;42(5):744-51. doi: 10.1016/j.jhep.2004.12.034. J Hepatol. 2005. PMID: 15826725

8

Short-term treatment duration for HCV-2 and HCV-3 infected patients.

Andriulli A, Dalgard O, Bjøro K, Mangia A. Andriulli A, et al. Among authors: mangia a. Dig Liver Dis. 2006 Oct;38(10):741-8. doi: 10.1016/j.dld.2006.06.006. Epub 2006 Aug 17. Dig Liver Dis. 2006. PMID: 16916631

9

Short-duration therapy for hepatitis C: suitable for all?

Mangia A. Mangia A. J Viral Hepat. 2007 Apr;14(4):221-7. doi: 10.1111/j.1365-2893.2006.00817.x. J Viral Hepat. 2007. PMID: 17381713 Review.

10

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms.

Pazienza V, Clément S, Pugnale P, Conzelman S, Foti M, Mangia A, Negro F. Pazienza V, et al. Among authors: mangia a. Hepatology. 2007 May;45(5):1164-71. doi: 10.1002/hep.21634. Hepatology. 2007. PMID: 17465001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page